Home/Filings/4/0001209191-15-057225
4//SEC Filing

Seres Therapeutics, Inc. 4

Accession 0001209191-15-057225

$MCRBCIK 0001609809operating

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 6:12 PM ET

Size

11.5 KB

Accession

0001209191-15-057225

Insider Transaction Report

Form 4
Period: 2015-06-26
NESTLE SA
10% Owner
Transactions
  • Conversion

    Common Stock, $0.001 par value

    2015-06-26+3,611,1115,555,555 total(indirect: See Footnote)
  • Conversion

    Series D Convertible Preferred Stock

    2015-06-263,611,1110 total(indirect: See Footnote)
    Common Stock (3,611,111 underlying)
Transactions
  • Conversion

    Common Stock, $0.001 par value

    2015-06-26+3,611,1115,555,555 total(indirect: See Footnote)
  • Conversion

    Series D Convertible Preferred Stock

    2015-06-263,611,1110 total(indirect: See Footnote)
    Common Stock (3,611,111 underlying)
Transactions
  • Conversion

    Common Stock, $0.001 par value

    2015-06-26+3,611,1115,555,555 total(indirect: See Footnote)
  • Conversion

    Series D Convertible Preferred Stock

    2015-06-263,611,1110 total(indirect: See Footnote)
    Common Stock (3,611,111 underlying)
Footnotes (3)
  • [F1]Held by Nestle Health Science US Holdings, Inc. Nestle Health Science US Holdings, Inc. is a wholly owned, indirect subsidiary of NIMCO US, Inc., which is a wholly ownd subsidiary of Nestle S.A., a publically traded company. Each of these entities may be deemed to share voting and investment power with respect to all shares held by Nestle Health Science US Holdings, Inc. Eahc of the filing entities disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.
  • [F2]The Series D Preferred Stock converted into Common Stock on a 1-for-1 basis upon the listing of the issuer's shares on The NASDAQ Global Select Market. The Series D Preferred Stock had no expiration date.
  • [F3]Not applicable.

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001609809

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 6:12 PM ET
Size
11.5 KB